๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin

โœ Scribed by S. Gerald Sandler

Book ID
114481610
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
901 KB
Volume
15
Category
Article
ISSN
1532-9496

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The cost of treating immune thrombocytop
The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin
โœ Sandler, S. Gerald; Novak, Sharon C.; Roland, Barbara ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 18 KB ๐Ÿ‘ 2 views

Multiple factors, including efficacy, toxicity and cost, may influence the decision to treat immune thrombocytopenic purpura (ITP) with intravenous immune globulin (IVIG) or intravenous Rho (D) immune globulin (IV RhIG). We conducted a survey of 50 hospitals in 31 states to determine the costs for t

Successful prevention of post-transfusio
Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD)
โœ Anderson, Barry; Shad, Aziza T.; Gootenberg, Joseph E.; Sandler, S. Gerald ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 18 KB ๐Ÿ‘ 2 views

Alloimmunization to the D blood group antigen following the transfusion of D-positive red blood cells to a D-negative recipient may be prevented in most persons by a prompt and adequate dose of Rho (D) immune globulin (RhIG). Until recently, the only RhIG approved by the US Food and Drug Administrat